West Pharmaceutical Services Net Income 2010-2023 | WST

West Pharmaceutical Services annual/quarterly net income history and growth rate from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • West Pharmaceutical Services net income for the quarter ending December 31, 2023 was $0.137B, a 33.01% increase year-over-year.
  • West Pharmaceutical Services net income for the twelve months ending December 31, 2023 was $0.593B, a 1.28% increase year-over-year.
  • West Pharmaceutical Services annual net income for 2023 was $0.593B, a 1.28% increase from 2022.
  • West Pharmaceutical Services annual net income for 2022 was $0.586B, a 11.47% decline from 2021.
  • West Pharmaceutical Services annual net income for 2021 was $0.662B, a 91.16% increase from 2020.
West Pharmaceutical Services Annual Net Income
(Millions of US $)
2023 $593
2022 $586
2021 $662
2020 $346
2019 $242
2018 $207
2017 $151
2016 $144
2015 $96
2014 $127
2013 $112
2012 $81
2011 $76
2010 $65
2009 $73
West Pharmaceutical Services Quarterly Net Income
(Millions of US $)
2023-12-31 $137
2023-09-30 $161
2023-06-30 $155
2023-03-31 $140
2022-12-31 $103
2022-09-30 $121
2022-06-30 $189
2022-03-31 $174
2021-12-31 $148
2021-09-30 $176
2021-06-30 $187
2021-03-31 $151
2020-12-31 $98
2020-09-30 $82
2020-06-30 $91
2020-03-31 $74
2019-12-31 $64
2019-09-30 $56
2019-06-30 $66
2019-03-31 $55
2018-12-31 $52
2018-09-30 $55
2018-06-30 $56
2018-03-31 $44
2017-12-31 $0
2017-09-30 $51
2017-06-30 $39
2017-03-31 $61
2016-12-31 $39
2016-09-30 $38
2016-06-30 $45
2016-03-31 $22
2015-12-31 $33
2015-09-30 $2
2015-06-30 $28
2015-03-31 $33
2014-12-31 $31
2014-09-30 $31
2014-06-30 $38
2014-03-31 $27
2013-12-31 $24
2013-09-30 $27
2013-06-30 $30
2013-03-31 $32
2012-12-31 $21
2012-09-30 $15
2012-06-30 $16
2012-03-31 $29
2011-12-31 $19
2011-09-30 $17
2011-06-30 $20
2011-03-31 $20
2010-12-31 $6
2010-09-30 $18
2010-06-30 $22
2010-03-31 $20
2009-12-31 $20
2009-09-30 $17
2009-06-30 $20
2009-03-31 $15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $28.565B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.909B 18.71
Becton Dickinson (BDX) United States $67.707B 19.66
Cardinal Health (CAH) United States $25.143B 15.11
Align Technology (ALGN) United States $23.470B 47.33
Cooper (COO) United States $18.222B 27.57
Labcorp (LH) United States $17.496B 14.94
Henry Schein (HSIC) United States $9.348B 16.17
DENTSPLY SIRONA (XRAY) United States $6.399B 16.86
Merit Medical Systems (MMSI) United States $4.307B 24.65
STAAR Surgical (STAA) United States $2.355B 74.14
Patterson (PDCO) United States $2.327B 11.15
CONMED (CNMD) United States $2.196B 20.67
Atrion (ATRI) United States $0.713B 36.74
Lifevantage (LFVN) United States $0.082B 13.34
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00